Low-Dose Atypical Antipsychotic Risperidone Improves the 5-Year Outcome in Alzheimer's Disease Patients with Sleep Disturbances

Publisher: Karger

E-ISSN: 1423-0313|96|3-4|155-162

ISSN: 0031-7012

Source: Pharmacology, Vol.96, Iss.3-4, 2015-08, pp. : 155-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content